Psoriasis and the risk of migraines in the United States - 14/04/20
Doi : 10.1016/j.jaad.2019.10.050
Alexa B. Steuer, MPH, Jeffrey M. Cohen, MD, Priscilla W. Wong, MS, Roger S. Ho, MD, MS, MPH ⁎ 
Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York
∗Correspondence to: Roger S. Ho, MD, MS, MPH, Ronald O. Perelman Department of Dermatology, New York University School of Medicine, 240 E 38th St, 12th floor, New York, NY 10016Ronald O. Perelman Department of DermatologyNew York University School of Medicine240 E 38th St, 12th floorNew YorkNY10016
| Funding sources: None. |
|
| Conflicts of interest: Dr Ho served on the advisory board for Valeant Pharmaceuticals. The authors have no other conflicts of interest to declare. |
|
| Portions of this work were presented as a poster at the International Dermatology Outcome Measures 2018 Annual Meeting, Washington, DC, May 4 and 5, 2018. |
|
| Reprints not available from the authors. |
© 2019
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 82 - N° 5
P. 1225-1226 - mai 2020 Retour au numéro
Article précédent
- Home-based contact immunotherapy with diphenylcyclopropenone improves compliance with the recommended follow-up for patients with alopecia areata: A retrospective cohort study
- Beom Jun Kim, Solam Lee, Chung Hyeok Lee, Won-Soo Lee
- Association between micronutrient deficiency dermatoses and clinical outcomes in hospitalized patients
- Rachel L. Marsh, John Trinidad, Sabrina Shearer, Benjamin H. Kaffenberger
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?